Minimal analgesia for major neonatal surgery — Institutional beliefs

Current understanding

Newborns have functional nociceptive pathways and mount organized physiological, hormonal, behavioral and neurological responses to painful surgery. Adequate anesthesia and analgesia are indicated for neonatal surgical procedures, with drug choice and dosing adapted to the infant's considerable physiological vulnerability.

Consequences and human impact

The belief was not confined to theory. It shaped neonatal anesthesia regimens in which paralysis and nitrous oxide could be used without potent analgesia during major surgery. Controlled work in the 1980s showed that untreated surgical stress produced markedly greater hormonal responses and more postoperative circulatory and metabolic complications.

How the consequences followed

The historical correction is not that neonatal anesthesia had never been used. Clinicians were balancing genuine anesthetic risks in tiny, unstable patients against an incorrect or underestimated model of neonatal pain.

The John Radcliffe episode is a documented institutional practice rather than a claim that every hospital used an identical regimen.

1987

Randomized fentanyl trial showed that deeper analgesia reduced the neonatal surgical stress response

8 + 8 infants

Preterm infants in the pivotal randomized comparison with and without fentanyl

1987

American Academy of Pediatrics policy stated that anesthesia or analgesia was indicated for neonatal surgery

Quantitative figures are highlighted only when the cited evidence supports them. The scale of a related catastrophe is not automatically treated as a death toll caused solely by this belief.

Institutional episode

United Kingdom

1982–1987Institutionally influential

At Oxford's John Radcliffe Hospital in the early 1980s, a neonatal anesthetic regimen using nitrous oxide and curare without potent analgesia represented accepted practice for major surgery. Anand and colleagues tested that practice in preterm infants undergoing ductus arteriosus ligation. Adding fentanyl sharply reduced the hormonal and metabolic stress response, while the infants who did not receive fentanyl had more postoperative circulatory and metabolic complications. In the same year, the American Academy of Pediatrics formally stated that available local or systemic agents allowed relatively safe anesthesia or analgesia and that such treatment was indicated for neonatal surgery.

Institutions

John Radcliffe Hospital, Oxford

Documented consequences

Preterm infants undergoing patent ductus arteriosus ligation could receive nitrous oxide and neuromuscular paralysis without a potent opioid analgesic
In the randomized comparison, infants without fentanyl showed significantly larger hormonal and metabolic stress responses
The non-fentanyl group also experienced postoperative circulatory and metabolic complications not seen to the same extent in the fentanyl group
The evidence helped force neonatal pain from an assumed limitation of immature physiology into an explicit anesthesia and analgesia requirement

Institutional machinery

Kanwaljeet Anand later described nitrous oxide plus curare, without potent analgesia, as the state-of-the-art neonatal anesthetic practice at John Radcliffe Hospital when he arrived in 1982. The rationale reflected both long-standing doubts that newborns perceived pain normally and legitimate fears about anesthetic toxicity and physiological instability. The hospital then became the setting for the randomized work that directly tested whether adding fentanyl changed the biological response to surgery.

Sources and what they establish

Discovering Pain in Newborn InfantsAnesthesiology / PubMed Central
Randomised trial of fentanyl anaesthesia in preterm babies undergoing surgery: effects on the stress responseThe Lancet / PubMed